Hong Kong stock market
Get more with myNEWS
A personalised news feed of stories that matter to you
Learn more
Brighter days ahead for investment bankers as big IPO deals return to Hong Kong market. Photo: Dickson Lee

Hong Kong’s dry spell for new stock offerings set to end with big China IPO deals

  • The pick up speaks of an improving environment for valuations as virus-related curbs are eased and Beijing dials back on corporate crackdown
  • Tianqi Lithium’s potential US$1.7 billion listing paves the way for July to be the strongest month for IPOs in Hong Kong this year

After a dismal first six months, things are finally looking up for initial public offerings (IPOs) in Hong Kong as several large Chinese firms line up to list in Asia’s financial hub in the second half.

Battery materials producer Tianqi Lithium Corp just opened its books for what is set to be the city’s first billion-dollar deal this year while China Tourism Group Duty Free Corp may relaunch an offering of around US$2 billion.

Along with several other mid- to large-sized deals in the pipeline, they are poised to revive a dormant market where firms raised a paltry US$2.6 billion between January and June. That is a 92 per cent slump from last year and the lowest sum for the same period since 2009.

The pick up in upcoming listings speaks of an improving environment for valuations as the easing of virus-related curbs and Beijing’s dialling back on a corporate crackdown spur a world-beating rally in stocks in China and Hong Kong. Better clarity on rules for Chinese share offerings abroad could also “encourage more new listings” in Hong Kong, Charles Zhou, an analyst at Credit Suisse wrote in a note last month.

The flow of positive news from China has propelled the benchmark CSI 300 Index toward a technical bull market and analysts are expecting more constructive policy reinforcements in the second half of the year.

“If it happens, that would hopefully help to push through some of our pipeline of equity deals that are waiting for a better market window to open,” said Selina Cheung, co-head of Asia equity capital markets at UBS Hong Kong.

In the first half, Hong Kong saw only one IPO that was larger than US$500 million. That was back in January plus the majority of companies that have debuted this year are trading below water. Notably, IPO activity has dried up globally as investors fret over inflation, hawkish central banks and recession fears.


Hong Kong’s dry spell now looks set to end with a flurry of small-size deals coming through late in June as issuers hurried to take advantage of a short window favouring Chinese equities.


HKEX CEO Nicolas Aguzin on the future of Hong Kong’s capital market

HKEX CEO Nicolas Aguzin on the future of Hong Kong’s capital market

Tianqi Lithium’s listing paves the way for July to be the strongest month for IPOs in the Asian financial hub this year. The pipeline of offerings of about US$500 million or more also includes snack maker Weilong Delicious Global Holdings and Wego Blood Purification, the dialysis unit of China’s Wego Group. China’s Imeik Technology, which has a market capitalisation of US$19 billion, has also filed for a listing in Hong Kong.

More regulatory clarity from Beijing for firms planning to sell their shares overseas will also be key going forward.

Many of the potential listings are already trading in New York but are trying to tap investors closer to home due to fears of being kicked out due to the regulatory impasse with the US.

Such is the case for consumer goods retailer Miniso Group, which is seeking up to US$116 million. Others have opted to go public in Asia by way of introduction, a mechanism that does not involve selling new shares.


A number of companies have “continuously” worked on their listing plans as they wait for a market window to reach ideal valuations, said Shi Qi, head of ECM at China International Capital Corp. “Looking ahead, companies related to stable growth policies and social well-being could see better opportunities in the market,” she said, citing themes like carbon neutrality, environmental governance, new energy, consumption and healthcare.